| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.50025751 |
| Immunoprecipitation analysis showed that zeta SG or gamma SG formed a SGC with beta SG and delta SG plus alpha SG or epsilon SG , revealing that zeta SG can form two types of SGCs ( alpha beta zeta delta or epsilon beta zeta delta ) . 0.50025751^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The absence of dystrophin leads to a dramatic reduction of the dystrophin associated proteins ( 156DAG , 59DAP , 50DAG , 43DAG and 35DAG ) in the sarcolemma of patients with Duchenne muscular dystrophy and mdx mice . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We recently reported that the dystrophin associated glycoprotein ( DAG ) complex is biochemically divided into two subcomplexes : one is the dystroglycan complex comprised of 156DAG and 43DAG and the other is the sarcoglycan complex comprised of 50DAG , A3b , and 35DAG . ^^^ In the present study , we examined the striated muscles of the dystrophic hamster with anti A3b antibody in addition to anti 50DAG , anti 43DAG , anti 35DAG , anti dystrophin , and anti laminin antibodies by both immunohistochemistry and immunoblot analysis and found that 50DAG , A3b , and 35DAG are selectively lost . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In particular , we found that the glycoprotein complex stated above was dissociated into two distinct groups : one composed of 156DAG and 43DAG ( A3a ) and the other composed of 50DAG , 35DAG and A3b . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Dystrophin associated glycoprotein complex is classified into two subcomplexes : the dystroglycan complex ( 156DAG and 43DAG ) and the sarcoglycan complex ( 50DAG , A3b , and 35DAG ) . ^^^ We examined muscles from five SCARMD patients and found that dystrophin and 43DAG were present in almost normal levels while 35DAG and the newly identified protein A3b in addition to 50DAG were absent or greatly reduced . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Antibodies against dystrophin , utrophin and DAGs including 50DAG ( A 2 ) , 43DAG ( A3a ) and 35DAG ( A 4 ) were employed for the examination . ^^^ On the other hand , in the dystrophic hamster 50DAG ( A 2 ) and 35DAG ( A 4 ) were selectively defective , and 43DAG ( A3a ) was also decreased , although to a lesser degree . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Dystrophin associated proteins are comprised of an extracellular glycoprotein of 156 kDa ( 156DAG ) , transmembrane glycoproteins of 50 kDa ( 50DAG ) , 43 kDa ( 43DAG ) and 35 kDa ( 35DAG ) , and a cytoskeletal protein of 59 kDa ( 59DAP ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The dystrophin associated proteins are classified into three groups : ( 1 ) alpha and beta dystroglycan , ( 2 ) adhalin , 35DAG and A3b , and ( 3 ) members of the syntrophin family . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We show by immunofluorescence and Western blotting that in skeletal muscle from these patients gamma sarcoglycan is completely absent and alpha and beta sarcoglycan are greatly reduced in abundance , whereas other components of the DGC are preserved . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Two of the four have microdeletions that disrupt the distal carboxyl terminus of gamma sarcoglycan yet result in a complete absence of gamma and beta sarcoglycan suggesting the importance of this region for stability of the sarcoglycan complex . ^^^ This region of gamma sarcoglycan , like beta sarcoglycan , has a number of cysteine residues similar to those in epidermal growth factor cysteine rich regions . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Screening for sarcoglycan gene mutations in 50 of the 54 patients revealed mutations in 29 patients ( 58 percent ) : 17 ( 34 percent ) had mutations in the alpha sarcoglycan gene , 8 ( 16 percent ) in the beta sarcoglycan gene , and 4 ( 8 percent ) in the gamma sarcoglycan gene . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Pathogenetic mutations involving one gene for sarcoglycan complex components were identified in 13 patients : alpha sarcoglycan in seven , beta sarcoglycan in two , gamma sarcoglycan in four , and none in the delta sarcoglycan gene . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We investigated the expression of alpha sarcoglycan , beta sarcoglycan , gamma sarcoglycan , and delta sarcoglycan immunohistochemically in three patients with mutations of the alpha sarcoglycan gene and a patient with a mutation of the gamma sarcoglycan gene . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The absence of sarcoglycan leads to alterations of membrane permeability and apoptosis , two shared features of a number of dystrophies . beta sarcoglycan and delta sarcoglycan may form the core of the sarcoglycan subcomplex with alpha and gamma sarcoglycan less tightly associated to this core . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The classification of families was as follows : calpainopathy 7 , dysferlinopathy 3 , alpha sarcoglycan deficiency 2 , beta sarcoglycan deficiency 7 , gamma sarcoglycan deficiency 5 , delta sarcoglycan deficiency 1 , and merosinopathy 2 . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| An 8 bp duplication in the beta sarcoglycan gene and 1 bp insertion in the gamma sarcoglycan gene occur with high frequency in our population . ^^^ We found that the 8 bp duplication in the beta sarcoglycan gene and the 1 bp insertion in the gamma sarcoglycan gene are in linkage disequilibrium with neighbouring polymorphisms . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemical studies of muscle biopsy showed a total absence of gamma sarcoglycan , a normal or slightly reduced alpha and delta sarcoglycans whereas the expression of beta sarcoglycan was variable . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| They are : calpain 3 ( LGMD2A ) , dysferlin ( LGMD2B ) , alpha sarcoglycan ( LGMD2D ) , beta sarcoglycan ( LGMD2E ) , gamma sarcoglycan ( LGMD2C ) , delta sarcoglycan ( LGMD2F ) , telethonin ( LGMD2G ) , TRIM 32 ( LGMD2H ) , fukutin related protein ( LGMD2I ) and titin ( LGMD2J ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| RESULTS : We validate the temporal Hotelling T 2 test on muscular gene expression data from four mouse strains which were profiled at different ages : dystrophin , beta sarcoglycan and gamma sarcoglycan deficient mice , and wild type mice . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Sarcoglycanopathies are a genetically heterogeneous group of autosomal recessive muscular dystrophies in which the primary defect may reside in any of the genes coding for the different partners of the sarcolemmal sarcoglycan ( SG ) complex : the alpha SG ( LGMD2D at 17q21 . 2 ) , the beta SG ( LGMD2E at 4q12 ) , the gamma SG ( LGMD2C at 13q12 ) , and the delta SG ( LGMD2F at 5q33 ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Five genes have already been identified : calpain 3 at LGMD2A ( 15q15 ) , and four members of the sarcoglycan ( SG ) complex , alpha SG at LGMD2D ( 17q21 ) , beta SG at LGMD2E ( 4q12 ) , gamma SG at LGMD2C ( 13q12 ) , and delta SG at LGMD2F ( 5q33 q 34 ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Eight genes are mapped for the AR LGMDs ; they are : LGMD2A ( CAPN 3 ) at 15q , LGMD2B ( dysferlin ) at 2p , LGMD2C ( gamma SG ) at 13q , LGMD2D ( alpha SG ) at 17q , LGMD2E ( beta SG ) at 4q , LGMD2F ( 6 SG ) at 5q , LGMD2G at 17q , and more recently LGMD2H at 9q . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Sarcoglycanopathies ( SGPs ) constitute a subgroup of limb girdle muscular dystrophies ( LGMD ) , where the primary defect in one sarcoglycan ( SG ) glycoprotein ( alpha SG , beta SG , gamma SG or delta SG ) results in a deficiency of the whole complex . ^^^ DNA analysis for the four sarcoglycan genes showed that alpha SG mutations accounted for 47 % , beta SG for 16 % , gamma SG for 16 % and delta SG for 21 % of the cases . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The SG complex consists of four transmembrane glycoproteins , alpha SG , beta SG , gamma SG and delta SG . ^^^ We found that beta SG and delta SG were co expressed with epsilon SG , a alpha SG homolog , in the peripheral nerve , but not with alpha SG or gamma SG . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We have also provided evidence that glycosylation defective mutations in beta SG and a common mutation in gamma SG ( C283Y ) disrupt sarcoglycan complex formation . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| A subgroup among the autosomal recessive forms comprises the sarcoglycanopathies ( LGMD2C 2F ) , caused by mutations in the gamma ( gamma SG ) , alpha ( alpha SG ) , beta ( beta SG ) and delta ( delta SG ) sarcoglycan genes , respectively . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| There was a reduction in the alpha SG in 7 patients , beta SG in 4 , gamma SG in 2 , and delta SG in 8 . ^^^ There was deficiency of alpha SG in 7 patients , beta SG in 6 , gamma SG in 9 , delta SG in 5 , dysferlin in 8 , and calpain 3 in 5 . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| An autosomal dominant form ( LGMD1A ) has been mapped at 5q22 . 3 31 . 3 , while five genes responsible for the autosomal recessive forms were mapped respectively at : 15q15 . 1 ( LGMD2A ) , 2p12 p 16 ( LGMD2B ) , 13q12 ( LGMD2C ) , 17q12 q21 . 33 ( LGMD2D ) and 4q12 ( LGMD2E ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| One autosomal dominant ( LGMD1A , at chromosome 5q22 . 3 31 . 3 ) ( ref . 3 ) and five autosomal recessive ( AR ) loci responsible for this phenotype have been identified : LGMD2A at 15q ( ref . 4 ) ; LGMD2B at 2p ( ref . 5 ) , LGMD2C at 13q ( ref . 6 ) , LGMD2D at 17q ( ref . 7 ) and LGMD2E at 4q ( refs 8 , 9 ) . ^^^ The genes for LGMD2C , LGMD2D and LGMD2E code for proteins of the SG complex . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Recently six different loci for LGMD have been reported : 5q ( LGMD1A ) , 15q ( LGMD2A ) , 2p ( LGMD2B ) , 13q ( LGMD2C ) , 17q ( LGMD2D ) and 4p 14 q21 . 2 ( LGMD2E ) respectively . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemical analysis of skeletal muscle biopsies from patients with LGMD2C , LGMD2D , and LGMD2E demonstrated a reduction of the entire sarcoglycan complex in these muscular dystrophies . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| This clinical heterogeneity has been demonstrated at the molecular level , since the genes for six AR forms have been cloned and / or have been mapped to 15q15 . 1 ( LGMD2A ) , 2p12 16 ( LGMD2B ) , 13q12 ( LGMD2C ) , 17q12 q21 . 33 ( LGMD2D ) , 4q12 ( LGMD2E ) , and 5q33 34 ( LGMD2F ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The marker loci were genotyped in 96 LGMD 2 families leading to genetic definition of 25 of them either with a high likelihood or with a suggested localization ( 7 LGMD2A , 5 LGMD2B , 4 LGMD2C , 4 LGMD2D , 2 LGMD2E and 3 LGMD2F ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| LGMD2C , LGMD2D , LGMD2E , LGMD2F ] . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We have designed Multiplex Amplifiable Probe Hybridization ( MAPH ) probes for 28 exons of the sarcoglycan genes SGCA , SGCB , SGCG , and SGCD . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| To get a closer view on the differentiating molecular events responsible for the muscular dystrophies , we have carried out a comparative gene expression profiling of hindlimb muscles of the following mouse models : dystrophin deficient ( mdx , mdx ( 3cv ) ) , sarcoglycan deficient ( Sgca null , Sgcb null , Sgcg null , Sgcd null ) , dysferlin deficient ( Dysf null , SJL ( Dysf ) ) , sarcospan deficient ( Sspn null ) , and wild type ( C57Bl / 6 , C57Bl / 10 ) mice . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Mutations in SGCA , SGCB , SGCG and SGCD genes are associated with LGMD 2D , 2E , 2C and 2F , respectively . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The SGC cells have two or more , long , axon like processes , receive a heavy innervation , and contain small synaptic like vesicles in addition to the dense cored secretory granules of neurosecretory type . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Another type of SGC cells contained granular vesicles with cores of low to medium electron density ( SGC NA negative cells ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| According to the fine structure of dense cored vesicles ( DCVs ) in the cytoplasm , three types of small granule containing ( SGC ) cells were revealed Type 1 : 90 160 nm vesicles with cores of moderate or low electron density ; Type 2 : 130 330 nm vesicles , polymorphic with highly electron dense cores ; Type 3 : elongated vesicles ( 170 nm 10 60 nm ) with cores of moderate to low electron density . ^^^ The majority of SGC cells were the Type 1 cells ( 78 % ) and Type 2 and 3 cells made up 13 % and 9 % of SGC cell population , respectively . ^^^ Cytochemical results demonstrated that only the Type 2 cells displayed a positive chromaffin reaction and all three types of SGC cells showed argentaffinity and uranaffinity . ^^^ Based on the results of the present study we also concluded that ( 1 ) the DCVs of Type 2 SGC cells contained noradrenaline and ( 2 ) biogenic amines and nucleotides ( ATPs ) coexisted in the DCVs of all three types of SGC cells . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| These data suggest that CAP and CM recovery at low and middle frequencies following acute TMT administration is accompanied by recovery of neurotransmission at the IHC or Type 1 SGC level and OHC recovery at apical regions of the cochlea . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The results showed that the nuclear DNA content was related to the malignancy of SGC , based on the clinical and morphological criteria such as tumor size , mobility , property of growth , mitotic rate , degree of differentiation and the histological type of the tumor . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The authors compared the post antibiotic effect ( PAE ) of imipenem , amikacin , ciprofloxacin , and latamoxef against Serratia marcescens ATCC 13880 ( type strain ) and against 12 clinical strains belonging to Grimont ' s most frequent biotypes : A2a , A3a , A3b , A4a , A4b , A 5 , A6a , A8a , A8b , A8c , TT , TCT . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| However , AB 3 , A2B2 , and A3B , which are mono , di , and trivalent for alpha D GalNAcp , were differentially precipitated by type A blood group substance which contains alpha D GalNAcp end groups . ^^^ A3B precipitated the most , A2B2 less , and AB 3 no type A substance . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In aged rats , a third type of SGC cells containing 50 10 250 nm elongated dense core vesicles could also be distinguished . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In aged rats a third type of SGC cell containing elongated 50 10 250 nm dense cored vesicles was found . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Type 1 17 HSD protein concentration , 17 HSD and cytochrome P 450 aromatase ( P450arom ) activities and oestradiol ( OE 2 ) production in cells from LGC were significantly lower than the corresponding values obtained in SGC in the same patient ( paired t test ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We made a cytophotometric DNA analysis using 21 scirrhous gastric carcinomas ( SGC ) , and compared the results with those of 12 undifferentiated type early gastric carcinomas ( EGC ) located in the gastric body . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In addition to adrenalin ( A ) and noradrenaline ( NA ) containing cells in the hamster adrenal medulla , a third type of small granule containing ( SGC ) cells was identified . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The drug induced a rightward shift of the concentration response curves recorded with two different NO donors and a reduction of maximal sGC activity , pointing to a mixed type of inhibition . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Electron microscopic observation revealed that most capillaries surrounding the principal neurons in these ganglia were of the continuous ( non fenestrated ) type , while the fenestrated capillaries were consistently associated with the small granule containing ( SGC ) cells in rat and hamster superior cervical ganglia and the coeliac mesenteric ganglia ( CMG ) complex . ^^^ Both of the capillaries surrounding the principal neurons and adjacent to SGC cells in various gerbil sympathetic ganglia or in rat and hamster thoracic ganglia were of the non fenestrated type . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Genomic screening for beta sarcoglycan gene mutations : missense mutations may cause severe limb girdle muscular dystrophy type 2E ( LGMD 2E ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Adhesion of cells to fibronectin or collagen type 1 coated dishes resulted in induction of tyrosine phosphorylation of alpha and gamma sarcoglycans but not beta sarcoglycan . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Screening of surfactants was carried out to develop an oil in water ( o / w ) emulsion type new vehicle for a soft gelatin capsule ( SGC ) , using polyethyleneglycol 400 ( PEG 400 ) as hydrophilic phase and medium chain triglyceride ( Miglyol 810 ) , propyleneglycol dicaprylate ( Sefsol 228 ) or soybean oil as hydrophobic phase ( PEG 400 : hydrophobic phase : surfactant = 87 : 10 : 3 ) and by means of simple homogenization . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The goal of this study in chick was to verify the existence of the type 1 and type 2 SGC neurons , as defined by Karten et al . , and then examine in greater detail the connectivity and morphology of these SGC neurons . ^^^ By injecting retrograde tracer into various divisions of the chick rotundus , we verified that , indeed , the chick did possess type 1 and type 2 SGC neurons , as well as a `` new ' ' type of SGC neuron , type 3 , that is not found in the pigeon . ^^^ Our examination revealed the following : Type 1 SGC neurons had large , circular dendritic fields ( average diameter , 1 , 725 microns ) composed of smooth dendrites and ending in spine rich , bottlebrush endings located in retinorecipient tectal layer 5b ; type 2 SGC neurons had elliptical dendritic fields ( average 1 , 447 microns ) and dendritic endings located never more superficially than tectal layer 8 ; and type 3 SGC neurons had large dendritic fields ( average 1 , 800 microns ) of unknown shape and bottlebrush dendritic endings located in retinorecipient tectal layer 4 . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Immunostaining , using specific antibodies to the three known NOS isoforms , to cyclic guanosine monophosphate ( cGMP ) and soluble guanylyl cyclase ( sGC ) , the second messenger system of nitric oxide ( NO ) , was performed on paraffin sections of temporal bone from guinea pigs . eNOS could be detected in vestibular ganglion cells and in nerve fibres , including the calyces , surrounding the type 1 hair cells ( HC ) . bNOS was found in the sensory epithelium , ganglion cells and in bone , while iNOS could not be found . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| This series of isolectins is tetravalent ( A 4 ) , trivalent ( A3B ) , divalent ( A2B2 ) , and monovalent ( AB 3 ) for type A erythrocytes ; thus , this system provides the opportunity to examine the effect of lectin valency on the association constants of these GS 1 isolectins binding to cells . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Neoglycoconjugates derived from GlcC , GalC ( type 1 and 2 and the behenic analog ) , SGC , LC , and Gb3C were recognized by the recombinant human immunodeficiency virus coat protein gp 120 ( rgp 120 ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The sensitivity of the soluble guanylate cyclase ( sGC ) cyclic guanosine 3 ' , 5 ' monophosphate ( cyclic GMP ) system to nitric oxide ( NO ) was investigated in mouse aorta from wild type ( WT ) and NO synthase ( NOS ) knockout ( KO ) animals . 2 . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Disruption of the beta sarcoglycan gene reveals pathogenetic complexity of limb girdle muscular dystrophy type 2E . ^^^ Limb girdle muscular dystrophy type 2E ( LGMD 2E ) is caused by mutations in the beta sarcoglycan gene , which is expressed in skeletal , cardiac , and smooth muscle . beta sarcoglycan deficient ( Sgcb null ) mice developed severe muscular dystrophy and cardiomyopathy with focal areas of necrosis . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In contrast , variations in enzyme abundance , and possibly also enzyme specific activity , appear responsible for differences in sGC activity associated with both age and artery type . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Age , gender , duration of SGC placement , type of central catheter used for exchange with the SGC , and CXRs and their reports were noted . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Using photoaffinity labelling , we have identified the cysteine 238 and cysteine 243 region in the alpha 1 subunit of sGC as the target for a new type of sGC stimulator . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemistry with antibodies against the alpha 1 , beta 1 and beta 2 sGC subunits showed that the larger part of positivity was present in the sarcolemma region of skeletal muscle fibers and colocalized with NOS 1 mainly in type 2 myofibers and with HO 2 in type 1 and type 2 myofibers . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Two of these , SGC type 1 and type 2 , constitute the major direct inputs to rotundal subdivisions that process various aspects of visual information , e . g . , motion and luminance changes . ^^^ In conclusion , the morphological distinct SGC type 1 and 2 neurons also have different response properties to retinal inputs . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Our aim was to localize the enzymes in question , i . e . , neuronal nitric oxide synthase ( nNOS ) , soluble guanylate cyclase ( sGC ) , and cGMP dependent kinase type 1 ( cGK 1 ) in rat small intestine by indirect immunofluorescence . nNOS staining was found in neurons of the myenteric plexus and in varicose nerve fibers mainly in the circular muscle layer . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Thus our objective was to characterize potential alterations in the expression and activity of soluble guanylate cyclase ( sGC ) and phosphodiesterase type 5 ( PDE 5 ) induced by increased pulmonary blood flow and pulmonary hypertension . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| CONCLUSIONS : Our data demonstrate that the region surrounding the cysteines 238 and 243 in the alpha 1 subunit of the sGC could play an important role in regulation of sGC activity and could be the target of this new type of sGC stimulators . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| This type of sGC activators represent a new class of compounds with a different pharmacological profile in comparison to the classical NO donors and they could be beneficial for the treatment of male erectile dysfunction . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| This novel type of sGC activator is a valuable research tool and may offer a new approach for treating cardiovascular diseases . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The GC molecules in the mutant were localized at the same anatomical sites in the nervous system as the SGC molecules in the wild type . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| The SGC type contains higher virus loads and exhibits faster infection rates , and is apparently more susceptible to WSSV infection . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Intracellular cGMP content was measured after stimulation of sGC by S nitroso N penicillamine ( SNAP ) or stimulation of pGC by natriuretic peptides [ urodilatin ( Uro ) , atrial natriuretic peptide ( ANP ) , or C type natriuretic peptide ( CNP ) ] for 1 min in the presence of phosphodiesterase inhibitors . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Soluble guanylyl cyclase activator YC 1 inhibits human neutrophil functions through a cGMP independent but cAMP dependent pathway . 3 ( 5 ' Hydroxymethyl 2 ' furyl ) 1 benzyl indazole ( YC 1 ) , a novel type of soluble guanylyl cyclase ( sGC ) activator , is useful in investigating the signaling of cGMP and may provide a new approach for treating cardiovascular diseases . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In the latter cell type , we showed that sGC alpha ( 1 ) promoter activity was dependent on the presence of its 5 ( ' ) unstranslated region ( 5 ( ' ) UTR ) . . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In contrast , sGC expression was maintained in renal tumours whatever the tumour type , a finding showing that tumour cells remain sensitive to the bioregulatory role of exogeneous NO ( * ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| STUDY OBJECTIVES : To compare the steady state pharmacokinetics and safety of saquinavir soft gelatin capsules ( SGC ) plus low dose ritonavir administered once / day in antiretroviral naive adult patients infected with the human immunodeficiency virus type 1 ( HIV 1 ) and to evaluate any sex related differences . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Rat clitorises express components of the proposed pathway : neuronal and endothelial NO synthases , soluble guanylyl cyclase ( sGC ) , type 5 phosphodiesterase ( PDE 5 ) , and BK ( Ca ) channels . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Since a diminished activity of vascular sGC has been reported in an animal model of type 2 diabetes , the sGC activity was assayed in vitro in internal mammary artery specimens obtained during bypass surgery from patients with and without type 2 diabetes . ^^^ Basal activity of sGC and its sensitivity to stimulation by DEA / NO and HMR 1766 were not different between control and type 2 diabetic patients : maximum stimulation by DEA / NO amounted to 475 + / 67 and 418 + / 59 pmol . mg ( 1 ) . min ( 1 ) in control and type 2 diabetic patients , respectively . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| PURPOSE : To evaluate the relationships among histopathological type , clinical malignant grade , and Ki 67 labeling index ( LI ) in sebaceous gland carcinoma ( SGC ) , conjunctival squamous cell carcinoma ( SCC ) , and conjunctival intraepithelial neoplasia ( CIN ) , with pterygium and normal conjunctiva as controls . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| OBJECTIVES : To retrieve the records of all salivary gland cancer ( SGC ) patients diagnosed in Finland between 1991 and 1996 and to evaluate the incidence , histological type and location of SGC , the treatment given and the outcome . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Evidence that growth on collagen type 1 downregulates soluble guanylyl cyclase ( sGC ) expression and the responsiveness of human mesangial cells to nitric oxide ( NO ) by activating specific integrin signals involving integrin linked kinase ( ILK ) is presented . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Consistent with a gC / FX stoichiometry of approximately 1 : 1 , 121+ / 6 125I sgC molecules were found to bind per wild type HSV 1 . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| We show evidence that these effects of NO are mediated via sGC , protein kinase G and cyclic ADP ribose , resulting in the release of Ca2+ from intracellular stores , probably of the ryanodine sensitive type . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Two sulphonated polystyrene divinylbenzene cation exchangers ( gel type Purolite SGC 100 10 10 MBH and macroporous Purolite C 160 MBH ) have been investigated for NH ( 4 ) ( + ) ions uptake from the ammonium rich simulated solutions , corresponding to the caustic condensate of the nitrogen fertilizers production . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| In the present study we have tested the hypothesis that angiotensin 2 ( AngII ) , acting on angiotensin type 1 receptors ( AT1R ) , can release NO within the NTS and that its actions are mediated by soluble guanylate cyclase ( sGC ) . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| Expression levels of HO 1 , HO 2 , sGC , and phosphodiesterase type 5 ( PDE 5 ) were examined with Western blot . ^^^ |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q13326 and Q16585 |
Pubmed |
SVM Score :0.0 |
| NA |
|